Showing results (441-450 of 650) with videos related to
Sort By:
Pageof 65
Nature Cancer|January 29, 2024
Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activationMeri Rogava, Tyler J Aprati, Wei-Yu Chi, et al.Nature Cancer|January 29, 2024
Aneuploidy and complex genomic rearrangements in cancer evolutionToby M Baker, Sara Waise, Maxime Tarabichi, et al.Nature Cancer|January 10, 2024
Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47Chunliu Huang, Xuefei Wang, Yingzhao Wang, et al.Nature Cancer|January 12, 2024
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trialStephen J Bagley, Zev A Binder, Lamia Lamrani, et al.Nature Cancer|March 23, 2024
Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogrammingXujia Wu, Huairui Yuan, Qiulian Wu, et al.Nature Cancer|March 20, 2024
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapiesAnton Dobrin, Pieter L Lindenbergh, Yuzhe Shi, et al.Nature Cancer|September 20, 2024
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual diseaseLea Lemaitre, Nia Adeniji, Akanksha Suresh, et al.Nature Cancer|September 17, 2024
Vascular heterogeneity of tight junction Claudins guides organotropic metastasisXunian Zhou, Valerie S LeBleu, Eliot Fletcher-Sananikone, et al.Nature Cancer|September 17, 2024
Targeting therapy-persistent residual diseaseXiaoxiao Sun, Lani F Wu, Steven J Altschuler, et al.Nature Cancer|March 1, 2024
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocolsOren Barboy, Akhiad Bercovich, Hanjie Li, et al.Pageof 65